Naloxone Hydrochloride Injection, Solution
Product Images NDC 76045-114

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 76045-114). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Fresenius Kabi Logo (Nal01 0006 01)

FDA Label Image

Structural Formula (Nal01 0006 02)

Structural Formula (Nal01 0006 02)
Chemical structure of Naloxone Hydrochloride, showing its morphinan-based molecular framework with key hydroxyl and epoxy groups labeled.*
FDA Label Image

Figure 1 (Nal01 0006 03)

Figure 1 (Nal01 0006 03)
Illustration showing the components of a Naloxone Hydrochloride injection package, including the outer package, a labeled syringe with a plunger rod, syringe barrel, Luer lock collar, and syringe tip cap, with notes not to remove the label or Luer lock collar.*
FDA Label Image

Figure 2 (Nal01 0006 04)

Figure 2 (Nal01 0006 04)
An instructional line drawing showing two hands peeling back a sealed blister pack to reveal a syringe inside. The image demonstrates the process of opening the packaging for an injectable product, likely Naloxone Hydrochloride injection based on the context.*
FDA Label Image

Figure 3 (Nal01 0006 05)

Figure 3 (Nal01 0006 05)
An instructional illustration showing hands unscrewing the cap from a prefilled syringe or vial. An arrow indicates the twisting motion required to remove the cap, likely demonstrating preparation for an injection.*
FDA Label Image

Fresenius Kabi Logo (Nal01 0006 06)

FDA Label Image

Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Syringe Label)
Label for Naloxone Hydrochloride Injection, USP 0.4 mg/mL solution. This single-dose vial label includes dosing marks for 0.5 mL and 1 mL volumes, indicating administration routes via intravenous (IV), intramuscular (IM), or subcutaneous injection. The label shows the Fresenius Kabi brand and includes a barcode and Rx only designation.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Print Mat Label)

Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Print Mat Label)
Label for Naloxone Hydrochloride Injection, USP 0.4 mg/mL in a 1 mL single-dose prefilled syringe. The label is purple and white, indicating usage for intravenous, intramuscular, or subcutaneous administration. It includes storage instructions, lot number, expiration date, and a barcode. Manufactured by Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Shelf Carton Panel)

Package Label (PRINCIPAL DISPLAY – Naloxone 1 mL Shelf Carton Panel)
Packaging label for Naloxone Hydrochloride Injection USP 0.4 mg/mL by Fresenius Kabi USA, LLC. The label indicates this is a solution for injection intended for intravenous, intramuscular, or subcutaneous use. It includes dosage instructions, storage conditions, and manufacturer information, along with barcodes and reference to single-dose prefilled syringes in a 24 x 1 mL pack.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Syringe Label)

Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Syringe Label)
Label for Naloxone Hydrochloride Injection, USP, 2 mg/2 mL (1 mg/mL) single-dose vial. Intended for intravenous, intramuscular, or subcutaneous use. Includes a 2 mL volume scale, Fresenius Kabi USA, LLC as the labeler, and a barcode. Rx only.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Print Mat Label)

Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Print Mat Label)
Naloxone Hydrochloride Injection USP 2 mg/2 mL (1 mg/mL) in a 2 mL single-dose prefilled syringe. The label indicates use for intravenous, intramuscular, or subcutaneous administration. It includes storage instructions, caution to protect from light, and discard unused portions. The labeler is Fresenius Kabi USA, LLC.*
FDA Label Image

Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Shelf Carton Panel)

Package Label (PRINCIPAL DISPLAY – Naloxone 2 mL Shelf Carton Panel)
Packaging label for Naloxone Hydrochloride Injection USP 2 mg/2 mL (1 mg/mL) by Fresenius Kabi USA, LLC. The label indicates it is for intravenous, intramuscular, or subcutaneous use, with 24 single-dose prefilled syringes of 2 mL each. The label includes storage instructions and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.